Enovis Debt to Equity Ratio 2010-2025 | ENOV
Current and historical debt to equity ratio values for Enovis (ENOV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Enovis debt/equity for the three months ending March 31, 2025 was 0.52.
| Enovis Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$2.26B |
$2.62B |
0.86 |
| 2024-12-31 |
$2.15B |
$2.56B |
0.84 |
| 2024-09-30 |
$2.22B |
$3.33B |
0.67 |
| 2024-06-30 |
$2.15B |
$3.29B |
0.66 |
| 2024-03-31 |
$2.17B |
$3.31B |
0.66 |
| 2023-12-31 |
$1.09B |
$3.42B |
0.32 |
| 2023-09-30 |
$0.96B |
$3.44B |
0.28 |
| 2023-06-30 |
$0.99B |
$3.45B |
0.29 |
| 2023-03-31 |
$0.85B |
$3.45B |
0.25 |
| 2022-12-31 |
$0.82B |
$3.45B |
0.24 |
| 2022-09-30 |
$1.04B |
$3.41B |
0.30 |
| 2022-06-30 |
$1.01B |
$3.49B |
0.29 |
| 2022-03-31 |
$3.84B |
$4.64B |
0.83 |
| 2021-12-31 |
$3.85B |
$4.66B |
0.83 |
| 2021-09-30 |
$3.34B |
$4.63B |
0.72 |
| 2021-06-30 |
$3.21B |
$4.35B |
0.74 |
| 2021-03-31 |
$3.78B |
$4.29B |
0.88 |
| 2020-12-31 |
$3.76B |
$3.59B |
1.05 |
| 2020-09-30 |
$3.70B |
$3.46B |
1.07 |
| 2020-06-30 |
$3.73B |
$3.40B |
1.10 |
| 2020-03-31 |
$4.12B |
$3.34B |
1.23 |
| 2019-12-31 |
$3.90B |
$3.49B |
1.12 |
| 2019-09-30 |
$6.46B |
$3.13B |
2.06 |
| 2019-06-30 |
$6.64B |
$3.26B |
2.04 |
| 2019-03-31 |
$6.76B |
$3.74B |
1.81 |
| 2018-12-31 |
$3.14B |
$3.48B |
0.90 |
| 2018-09-30 |
$2.97B |
$3.48B |
0.85 |
| 2018-06-30 |
$2.93B |
$3.54B |
0.83 |
| 2018-03-31 |
$3.04B |
$3.84B |
0.79 |
| 2017-12-31 |
$2.98B |
$3.73B |
0.80 |
| 2017-09-30 |
$3.33B |
$3.51B |
0.95 |
| 2017-06-30 |
$3.36B |
$3.37B |
1.00 |
| 2017-03-31 |
$3.22B |
$3.21B |
1.00 |
| 2016-12-31 |
$3.25B |
$3.09B |
1.05 |
| 2016-09-30 |
$3.37B |
$3.17B |
1.07 |
| 2016-06-30 |
$3.42B |
$3.16B |
1.08 |
| 2016-03-31 |
$3.49B |
$3.24B |
1.08 |
| 2015-12-31 |
$3.48B |
$3.26B |
1.07 |
| 2015-09-30 |
$3.74B |
$3.30B |
1.13 |
| 2015-06-30 |
$3.58B |
$3.43B |
1.05 |
| 2015-03-31 |
$3.70B |
$3.25B |
1.14 |
| 2014-12-31 |
$3.86B |
$3.35B |
1.15 |
| 2014-09-30 |
$3.99B |
$3.54B |
1.13 |
| 2014-06-30 |
$4.28B |
$3.65B |
1.17 |
| 2014-03-31 |
$3.38B |
$3.40B |
0.99 |
| 2013-12-31 |
$3.86B |
$2.74B |
1.41 |
| 2013-09-30 |
$3.76B |
$2.57B |
1.47 |
| 2013-06-30 |
$3.69B |
$2.40B |
1.54 |
| 2013-03-31 |
$3.78B |
$2.06B |
1.83 |
| 2012-12-31 |
$3.99B |
$2.16B |
1.85 |
| 2012-09-30 |
$3.88B |
$2.18B |
1.78 |
| 2012-06-30 |
$3.90B |
$2.10B |
1.85 |
| 2012-03-31 |
$3.91B |
$2.22B |
1.76 |
| 2011-12-31 |
$0.90B |
$0.19B |
4.75 |
| 2011-09-30 |
$0.79B |
$0.25B |
3.23 |
| 2011-06-30 |
$0.81B |
$0.25B |
3.18 |
| 2011-03-31 |
$0.83B |
$0.24B |
3.47 |
| 2010-12-31 |
$0.81B |
$0.22B |
3.72 |
| 2010-09-30 |
$0.78B |
$0.23B |
3.44 |
| 2010-06-30 |
$0.78B |
$0.19B |
4.23 |
| 2010-03-31 |
$0.80B |
$0.19B |
4.12 |
| 2009-12-31 |
$0.79B |
$0.22B |
3.64 |
| 2009-09-30 |
$0.83B |
$0.20B |
4.21 |
| 2009-06-30 |
$0.72B |
$0.18B |
3.91 |
| 2009-03-31 |
$0.72B |
$0.17B |
4.27 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$1.711B |
$2.108B |
|
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
|
